The Utility of Oncotype DX for Adjuvant Chemotherapy Treatment Decisions in Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative, Node-negative Breast Canc...

por Rizki, Hirah, Hillyar, Christopher, Abbassi, Omar, Miles-Dua, Sascha
Publicado 2020

An 81 Year Old with Back Pain

por Dubb, Sukhpreet S., Farrant, Joanna M., Praveen, B.V., Miles-Dua, Sascha
Publicado 2013

68-Year-Old Man with PR Bleed

por Dubb, Sukhpreet S., Farrant, Joanna M., Praveen, B.V., Miles-Dua, Sascha
Publicado 2013

Correlation Between Oncotype DX, PREDICT and the Nottingham Prognostic Index: Implications for the Management of Early Breast Cancer

por Hillyar, Christopher, Rizki, Hirah, Abbassi, Omar, Miles-Dua, Sascha, Clayton, Gillian, Gandamihardja, Tasha, Smith, Simon
Publicado 2020